Jesse Goodman, MD MPH has been appo...

Jesse Goodman, MD MPH has been appointed director of the FDA's Center for Biologics Evaluation and Research (CBER). He will replace Kathryn Zoon PhD who joined the FDA in 1980 and had serv as director since 1992 Zoon is returning to the National Institutes of Health as principal delegate director for research, in the Center for Cancer Research at the National Cancer Institute.
Goodman joined the FDA's Office